Capabilities · Technology transfer & contract manufacturing

Quality & technical agreements

A proposed service domain for formal quality documentation, connecting execution responsibilities, communication pathways, technical boundaries and applicable regulatory expectations.

PlannedCatalogue scope

Illustrative unbranded sanitary tri-clamp connection detail.
Illustrative unbranded sanitary tri-clamp connection detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Quality and technical agreements are presented as a planned service domain. The exact product, proposed manufacturing relationship and applicable regulatory route would strictly define its scope.

The proposed services catalogue introduces technical contract drafting as an administrative interest. It lies outside the initial project plan and would need formal scope confirmation.

Material supply arrangements and finished product manufacturing represent distinct legal and technical subjects. Inclusion in a common catalogue does not establish that one template applies universally.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Contract manufacturing agreementsDocumentation frameworks designed to establish formal responsibilities for routine batch production.Catalogue scopePlanned
Analytical testing agreementsFormal boundaries defining sample handling, method execution and data reporting obligations.Catalogue scopePlanned
Development phase agreementsAgreements tailored to investigational products, outlining data ownership and phase-appropriate controls.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Scope and boundary definition

Identify the intended manufacturing or analytical activities and the respective organisational boundaries.

02 · Process stage

Planned

Responsibility matrix drafting

Map the proposed allocation of tasks, review obligations and final decision authority.

03 · Process stage

Planned

Communication pathway alignment

Define the required notification timeframes for deviations, changes and analytical out-of-specification results.

04 · Process stage

Planned

Regulatory obligation mapping

Consider the applicable pharmacopoeial requirements and the relevant regulatory authority inspection commitments.

05 · Process stage

Planned

Document review and revision

Subject the drafted agreement to formal evaluation by the relevant quality units.

06 · Process stage

Planned

Final approval and implementation

Establish the agreed document as the binding framework for the proposed technical relationship.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Regulatory dossier support

Product-specific document structures and evidence requirements.

Explore proposed scope

02PlannedCatalogue scope

Clinical & commercial batch programmes

Distinct batch purposes, controls and applicable permissions.

Explore proposed scope

03PlannedCatalogue scope

Material sourcing & supplier assessment

Material identity, traceability and proposed supplier-evidence requirements.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product and activity
Exact description of the intended product and the specific manufacturing or analytical operations.
Facility and systems
Relevant qualification status and an approved scope for the proposed technical activities.
Process evidence
Defined procedural parameters and the required controls for the subject matter.
Quality responsibilities
Clear identification of the personnel accountable for review and formal decision rights.
Regulatory context
Applicable authorisations and relevant guidance concerning outsourced pharmaceutical operations.
Technical agreement
The formal document itself, fully negotiated and accepted by the involved entities.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating quality or technical agreement service.

Which agreement templates are in scope?

The exact documentation depends on the outsourced activity, product type and regulatory jurisdiction. All technical agreements would require separate drafting and formal scope confirmation.

What information helps define the question?

Identify the proposed product, outsourced activity, development stage, intended destination and the documentation question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, evidence and the fully executed agreement would need to be established before a service or supply commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma